Zydus Cadila supplies 30,000 COVID KAVACH Elisa test kits to ICMR

The kits, to be used for antibody detection of Covid-19, have been manufactured in collaboration (via technology transfer) with ICMR-NIV of Pune for surveillance purposes

Covid-19 sample
A medic works on a sample for COVID-19 Rapid Test at a camp during the nationwide lockdown imposed in a bid to contain the spread of coronavirus, in Bhubaneswar, Monday, April 20, 2020 | Photo: PTI
Vinay Umarji Ahmedabad
2 min read Last Updated : May 23 2020 | 11:00 AM IST
Cadila Healthcare (Zydus Cadila) on Thursday said it has supplied the first batch of 30,000 Covid Kavach ELISA test kits gratis to the Indian Council of Medical Research (ICMR).

The kits, to be used for antibody detection of Covid-19, have been manufactured in technology transfer with ICMR-National Institute of Virology (NIV) in Pune for surveillance purposes.

Pankaj R Patel, chairman of Cadila Healthcare, said the kits are being supplied at no cost.

Manufactured by Zydus Cadila, the test kits have been validated by NIV-Pune and were found to have high sensitivity and specificity. Termed Covid Kavach ELISA, the kits have been manufactured at the company’s Moraiya facility near Ahmedabad within four days of receiving requisite material from ICMR–NIV.

While reverse transcription polymerase chain reaction (RT-PCR) test kits are largely being used for testing Covid-19, the ELISA antibody test kits were approved by ICMR, after NIV-Pune successfully developed an indigenous IgG ELISA test for antibody detection of Covid-19.

The test is said to have the advantage of testing 90 samples together in a single run of two and  a half hours, with the ELISA kit making testing possible even at the district level.

After development at ICMR-NIV, technology has been commercialised by Zydus Cadila for large-scale production.

Earlier, Zydus Cadila had partnered ICMR to be better equipped against infectious disease outbreaks, and help high-risk individuals, particularly in remote areas of the country.

The company has been manufacturing and marketing a range of ELISA kits for detection and surveillance of rare and neglected diseases in humans and livestock.

The company has manufactured kits for Chandipura virus (ELISA), Kyasanur Forest disease virus (ELISA), Hepatitis E virus (ELISA), Crimean-Congo haemorrhagic fever (IgM and IgG tests) and measles (IgM) for human testing and Crimean-Congo haemorrhagic fever (ELISA kits for sheep, goat, and cattle) and Japanese Encephalitis (ELISA kits for mosquitoes).
Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldEditEdit in GingerEdit in Ginger×

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusZydus Cadila

Next Story